Free Virtual Consultations. Corona Virus Related Cases Click Here.
ACCIDENT NEWS

Elderly Man Killed in Pedestrian Crash on Coffee Road


Victim Hit by Car in Fatal Bakersfield Accident

Pedestrian Fatality 3

Bakersfield, CA (November 19, 2019) – A man was killed in a pedestrian crash in Bakersfield. The fatal accident occurred on the evening of November 19 on Coffee Road.

An 85-year-old man was walking across Coffee Road, near Granite Falls Drive. He was outside of a crosswalk when he was hit by a vehicle. The man died at the accident scene. The driver remained at the scene and is cooperating with police. 

Our heartfelt condolences go out to the friends and loved ones of the victim.

#Bakersfield

#93312


May 7, 2020

Pedestrian Injured in Crash at El Cajon Boulevard and Copeland Avenue

Driver Flees Scene of San Diego Accident...


January 20, 2020

Man Hit by Car After Exiting Vehicle on Interstate 80 Near Antelope CHP Scales

Victim Dies in Fatal Citrus Heights Crash ...


November 25, 2019

1 Killed in Crash on Dirt Road Near Hansen Road

Car Goes Down Embankment in Fatal Tracy Accident...

Free Police Report Request

We offer free consultation. No office visit required, we will get back to you within 24 hours.

  • This field is for validation purposes and should be left unchanged.

What can we do for you?

  • Answer your legal question.
  • Provide a Free Case Evaluation.
  • Schedule an appointment.

Why Choose Us?

  • Available 24/7
  • Trusted Since 1990
  • Local to You
  • Recovered $350,000,000
  • 5 Star Reviews
  • Free Case Evaluation
  • VIP Service
  • No Win, No Fee

Latest Law Post


May 22, 2020

Johnson & Johnson Discontinues Talc-Based Baby Powder

baby powder new Johnson & Johnson discontinued its talc-based baby powders in the United States and Canada because thousands of lawsuits claiming it was contaminated with asbestos created a sales decline.


May 18, 2020

FDA Issues Warnings To Two Manufacturers Of Breast Implants

The U.S. Food and Drug Administration (FDA) just issued warning letters to two manufacturers of breast implants for failing to comply with regulatory requirements. The FDA sent a warning letter to Allergan for failure to comply with requirements to conduct post-approval studies assessing the risks and long-term safety of two separate breast implant models. Both breast implant models were voluntarily recalled last year. The FDA also sent a warning letter to Ideal Implant Incorporated. That letter was sent for failing to comply with adverse event reporting requirements and current good manufacturing practice requirements. The letter was prompted by an inspection which was conducted earlier in 2020.